On 2025-05-12, MoonLake Immunotherapeutics (MLTX) announced earnings per share of $-0.63 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.76.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.73 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.76 | $-0.63 |
| 2025-02-26 | 2024-12-31 | $-0.63 | $-0.72 |
| 2024-11-07 | 2024-09-30 | $-0.44 | $-0.56 |
| 2024-08-07 | 2024-06-30 | $-0.28 | $-0.39 |
| 2024-05-07 | 2024-03-31 | $-0.21 | $-0.22 |
| 2024-02-29 | 2023-12-31 | $-0.21 | $-0.12 |
| 2023-11-14 | 2023-09-30 | $-0.22 | $-0.18 |
| 2023-08-10 | 2023-06-30 | $-0.25 | $-0.23 |
| 2023-05-12 | 2023-03-31 | $-0.28 | $-0.23 |
| 2023-03-20 | 2022-12-31 | $-0.32 | $-0.31 |
| 2022-11-14 | 2022-09-30 | $-0.32 | $-0.27 |
| 2022-08-12 | 2022-06-30 | -- | $-0.34 |
| 2022-05-16 | 2022-03-31 | -- | $-0.18 |